UNITED STATES SECURITIESAND EXCHANGE COMMISSIONWashington, D.C.FORM DOMB APPROVALOMB Number: 3235-0076Estimated Average burden hours per...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549SCHEDULE 14A Proxy Statement Pursuant to Section 14(a)of the Securities...
0001604191 false --12-31 0001604191 2022-07-15 2022-07-15 iso4217:USD...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549SCHEDULE 14AProxy Statement Pursuant to Section 14(a)of the Securities...
0001604191 false --12-31 0001604191 2022-07-07 2022-07-07 iso4217:USD...
0001604191 false 0001604191 2022-07-05 2022-07-05 iso4217:USD xbrli:shares...
0001604191 false --12-31 0001604191 2022-06-15 2022-06-15 iso4217:USD...
0001604191 false 0001604191 2022-05-27 2022-05-27 iso4217:USD xbrli:shares...
0001604191 false 0001604191 2022-05-26 2022-05-26 iso4217:USD xbrli:shares...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-256476 PROSPECTUS SUPPLEMENT (To Prospectus...
1554467955348130.665.42P0YP0Y2154883514855848645.20662.2500First Wave BioPharma, Inc.0001604191--12-312022Q1false7317P9M02154883514855848645.20662...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
false0001604191NASDAQ00016041912022-05-022022-05-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
false0001604191NASDAQ00016041912022-04-272022-04-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.